Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?

STUDY OBJECTIVES: The most commonly prescribed antibiotics for patients with hospital‐acquired bacterial pneumonia (HABP) and ventilator‐associated bacterial pneumonia (VABP) due to Pseudomonas aeruginosa are the conventional anti‐pseudomonal β‐lactams (APBLs) (ie, ceftazidime, cefepime, meropenem,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas P., Puzniak, Laura A., Chen, Lie H., Tian, Yun, Wei, Rong, Im, Theresa M., Tartof, Sara Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457199/
https://www.ncbi.nlm.nih.gov/pubmed/34097763
http://dx.doi.org/10.1002/phar.2600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457199/
https://www.ncbi.nlm.nih.gov/pubmed/34097763
http://dx.doi.org/10.1002/phar.2600

Ejemplares similares